AC Immune (ACIU) vs Yarrow Bioscience, Inc (YARW)

AC Immune and Yarrow Bioscience, Inc are both Biotechnology companies. AC Immune and Yarrow Bioscience, Inc are of similar size ($249.4M and $246.0M). Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −85.6%. AC Immune has the higher net margin (−1,783.7% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Yarrow Bioscience, Inc leads on 8 and AC Immune on 7.

Valuation

Metric ACIU YARW Biotechnology median
P/E n/m n/m 7.88
P/S 53.60 45.00 11.47
P/B 5.59 0.98 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.02 0.74
EV/Sales 34.13 (0.89) 10.73
Earnings yield (32.54%) (80.21%) (28.84%)
Free cash flow yield (33.65%) (78.93%) (23.03%)

Profitability

Metric ACIU YARW Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (1,745.75%) (4,134.44%) 0.00%
Net margin (1,783.66%) (3,881.54%) 0.00%
Free cash flow margin 0.00% (3,513.07%) 0.00%
Return on equity 0.00% (61.40%) (57.72%)
Return on assets 0.00% (54.77%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACIU YARW Biotechnology median
Revenue growth (TTM) (85.56%) 1.26% 5.64%
EPS growth (last fiscal year) (44.83%) 32.26% —
Revenue growth, 5-year CAGR (47.84%) (9.35%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACIU YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.93 15.26 4.73
Net debt to EBITDA 1.37 0.95 0.96

Dividend

Metric ACIU YARW Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACIU YARW Biotechnology median
Market cap 249.35m 246.04m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack